14.1 Homeostasis in Mammals

Homeostasis is the regulation of internal conditions so that a cell or organism maintains conditions suitable for normal function, despite internal or external change. A regulated variable can change, but it is kept within a functional range rather than allowed to drift without control.

Internal variables such as temperature, water potential, pH and dissolved respiratory gases affect enzyme action, membranes and cell function. Keeping them within workable limits protects the reactions and physical conditions on which cells depend.

A generic negative-feedback framework:

1. A receptor or sensor detects that a regulated variable has deviated from its acceptable range.
2. A coordination centre receives or processes the information and selects a corrective response.
3. An effector—such as a muscle or gland—changes its activity.
4. The response opposes the original deviation, so the variable moves back towards its functional range.
5. Monitoring continues; the response is reduced when the deviation is corrected.

Negative feedback does not mean the variable never changes, and homeostasis is not equilibrium or a permanently fixed value. This card gives the general control architecture; particular organs, hormones and named feedback examples belong to later cards.

Negative feedback is a control loop in which a deviation in a regulated variable triggers a response that opposes the original change. The aim is to return the variable towards its functional range, not to prevent all change.

Ordered control chain:

1. A stimulus moves a regulated variable away from its target or acceptable range.
2. A receptor detects the deviation and sends information to an integrating or coordination centre.
3. The coordinator compares the information with the required range and sends a signal to a suitable effector.
4. The effector changes its activity in the direction that opposes the original deviation.
5. As the variable returns towards its functional range, the corrective signal is reduced; monitoring then continues.

Generic read-off: if a variable rises above its functional range, the response should act to lower it; if it falls below the range, the response should act to raise it. The same receptor→coordinator→effector architecture can use nervous signals, hormones or both, depending on the control system.

“Negative” describes the response direction relative to the initial deviation; it does not mean harmful or ineffective. A response that amplifies the original change is positive feedback, not negative feedback. Specific organ, hormone and named physiological examples belong to later cards.

Excess amino acids cannot be stored as amino acids. In the liver, deamination removes the amino group and produces ammonia; the remaining carbon skeleton can be used in metabolism, while the nitrogen-containing waste is processed into urea.

Urea pathway boundary:

1. Excess amino acids are broken down and their amino groups are removed by deamination.
2. The removed nitrogen forms ammonia, which is very soluble and toxic if it accumulates in the blood.
3. Liver cells combine ammonia with carbon dioxide to form urea, a less toxic nitrogenous waste.
4. Urea dissolves in the blood and is transported to the kidneys.
5. The kidneys remove urea from the blood and it leaves the body in urine; this card does not describe nephron structure or the detailed formation of urine.

Converting ammonia to urea reduces the immediate toxicity of nitrogen waste and makes its transport in body fluids manageable. Water is required to carry dissolved urea and to remove it, so nitrogen excretion has a water-handling cost; the kidney-level details belong to later cards.

Urea is formed in the liver, not made by the kidney from scratch. Deamination is not the same as complete respiration of the carbon skeleton, and this card does not cover ultrafiltration, selective reabsorption or osmoregulation.

The kidney is organised into an outer cortex, an inner medulla and a central renal pelvis that leads to the ureter. This gross arrangement separates the region where blood is processed from the collecting route by which urine leaves the kidney.

Blood route and role

• The renal artery brings blood containing dissolved wastes and excess substances to the kidney.
• Processing occurs within the kidney; the renal vein carries the treated blood away.
• The cortex and medulla are regions of the kidney, not separate blood vessels or urine tubes.

Urine route and role

1. Urine formed within the kidney drains towards the renal pelvis.
2. The ureter carries urine from each kidney to the bladder for temporary storage.
3. The urethra carries urine from the bladder to the outside of the body.

The renal pelvis is therefore a collection and routing region; the ureter and urethra are transport/outflow structures.

Trace blood and urine as separate routes: the renal artery does not carry urine, and the renal vein does not carry filtrate. This card stays at whole-kidney anatomy; nephron microstructure, osmoregulation mechanisms and test-strip detection belong to later cards.

A nephron is the functional unit of the kidney. Its continuous tubule is organised into a renal corpuscle—glomerulus within Bowman’s capsule—followed by the proximal convoluted tubule, loop of Henle, distal convoluted tubule and collecting duct.

Segment → high-level role:

• Glomerulus + Bowman’s capsule: the renal corpuscle receives blood and forms filtrate from small dissolved substances.
• Proximal convoluted tubule: the early tubule is the main site where useful solutes and some water are selectively recovered.
• Loop of Henle: the tubule extends between cortex and medulla, supporting later control of water and solute movement.
• Distal convoluted tubule: a later segment where the filtrate composition can be adjusted before collection.
• Collecting duct: receives fluid from nephrons and carries the final urine towards the renal pelvis; its water permeability is regulated in a later osmoregulation card.

The renal corpuscles, proximal and distal tubules are mainly associated with the cortex, while loops of Henle and collecting ducts extend through the medulla. Blood capillaries alongside the tubule allow substances recovered from filtrate to return to the blood. Different segment structures therefore support different stages of filtrate processing without making the nephron itself a single uniform tube.

Filtrate is not yet final urine at Bowman’s capsule: its composition changes as it passes along the nephron. This card maps segment structure and broad roles; the full ultrafiltration/reabsorption mechanism, osmoregulation and test-strip detection belong to later cards.

Urine formation is a sequence, not a single filtration event: high-pressure ultrafiltration forms glomerular filtrate, selective reabsorption returns useful substances to the blood, and later tubular processing leaves a fluid that is carried out as urine.

Ordered process:

1. Ultrafiltration: high pressure in glomerular capillaries drives small molecules from the blood through the filtration barrier into Bowman’s capsule. Water and small solutes enter the glomerular filtrate; blood cells and large plasma proteins remain in the blood.
2. Selective reabsorption: as filtrate passes through the proximal convoluted tubule, useful solutes such as glucose, amino acids and appropriate ions are recovered into nearby blood capillaries; water follows where the relevant gradient permits.
3. Tubular processing: secretion can add selected substances from blood to the tubule, while later nephron regions continue adjusting the filtrate composition.
4. Urine route: the remaining fluid is urine, which passes through the collecting route towards the renal pelvis, ureter and bladder.

The filtration barrier makes an initial size-based separation, whereas reabsorption and secretion are selective cellular decisions. Therefore urine is not simply filtered blood: its final composition reflects what was retained, recovered and added along the nephron.

The process described here stops before ADH-controlled water permeability and detailed osmoregulation. It also does not cover blood-glucose test strips. Do not treat every filtered molecule as a final urinary waste or infer a complete urine composition from filtration alone.

Nephron segments are not equivalent tubes: their epithelial surfaces, transport capacity and water permeability differ. Those structural differences determine which substances can leave the filtrate, which are recovered to blood and how the filtrate is changed along its route.

Segment → structure/permeability → consequence:

• Proximal convoluted tubule: a brush border gives a large surface area, and many mitochondria provide ATP for active solute recovery; useful solutes are reabsorbed early.
• Descending limb of the loop of Henle: relatively permeable to water, so water can leave where the surrounding conditions allow; it is not equivalent to the ascending limb.
• Ascending limb: relatively impermeable to water and associated with ion movement, so it does not simply reabsorb water in the same way as the descending limb.
• Distal convoluted tubule: a later nephron segment where the filtrate composition can be adjusted before it enters the collecting duct.
• Collecting duct: its water permeability can be changed, so it determines how much water remains in the final urine; the hormone control of this change belongs to the osmoregulation card.

The nephron therefore uses structure as a control boundary: surface area and mitochondria support solute transport, contrasting loop permeability separates water and ion handling, and the collecting duct provides a final water-recovery checkpoint. The effects are segment-specific, not a single rule for the whole nephron.

The loop of Henle does not reabsorb water uniformly: its descending and ascending limbs have contrasting water permeability. This card explains segment structure and broad movement boundaries; it does not give the complete ADH/osmoregulation chain or any blood-glucose mechanism.

Osmoregulation keeps the water potential of body fluids within a functional range. When blood water potential falls, osmoreceptors detect the change and the ADH pathway makes the collecting duct more permeable to water, allowing more water to be recovered.

ADH control chain:

1. A fall in blood water potential is detected by osmoreceptors in the hypothalamus.
2. Nerve impulses stimulate the posterior pituitary gland to release antidiuretic hormone (ADH) into the blood.
3. ADH reaches the kidney and binds to receptors on collecting-duct cells.
4. Signalling causes aquaporin-containing vesicles to add water-permeable channels to the luminal membrane, increasing collecting-duct water permeability.
5. Water moves from the filtrate through aquaporins into the surrounding medullary tissue fluid and blood down a water-potential gradient.
6. The filtrate loses water and becomes a small volume of concentrated urine, reducing water loss.

When blood water potential is high, less ADH is released and fewer aquaporins remain in the collecting-duct membrane. Less water leaves the filtrate, so a larger volume of dilute urine is produced. The medullary gradient supplies the osmotic pull; ADH changes permeability so the existing gradient can act rather than directly pumping water or creating the gradient.

This card is the ADH/osmoregulation control chain, not the general nephron-segment map in 4682. It also does not cover blood-glucose test strips or other homeostatic systems.

When blood glucose falls, pancreatic alpha cells release glucagon. It acts mainly on liver cells to mobilise stored glycogen and support glucose production, increasing glucose release into the blood.

Glucagon control chain:

1. Alpha cells in the pancreatic islets detect a fall in blood glucose and release glucagon; beta-cell insulin secretion decreases.
2. Glucagon travels in the blood and binds to receptors on liver-cell membranes.
3. Liver-cell signalling activates enzymes that break glycogen down to glucose (glycogenolysis).
4. The liver releases more glucose into the blood, opposing the fall. If the fall persists, the liver can also support glucose production from non-carbohydrate substrates.

When blood glucose is high, insulin promotes glucose uptake and storage, whereas glucagon is the opposing low-glucose response. Together, these hormone pathways form negative feedback that returns blood glucose towards its functional range.

The glucagon enzyme cascade described here is a liver response; muscle glycogen is not directly released into the blood. This card covers hormonal control, not glucose test strips or biosensor readouts.

Blood glucose is regulated by opposing negative-feedback responses. A rise is detected by pancreatic beta cells, which release insulin to promote glucose uptake and storage; a fall is detected by alpha cells, which release glucagon to promote glucose release and production.

High blood glucose control:

1. Beta cells in the pancreatic islets release insulin.
2. Insulin stimulates glucose uptake by liver, muscle and adipose target cells; it also supports glucose use in respiration.
3. Insulin promotes glycogenesis, so glucose is stored as glycogen and the blood concentration falls towards its functional range.

Low blood glucose control:

1. Alpha cells release glucagon while insulin secretion decreases.
2. Glucagon acts mainly on liver cells to stimulate glycogenolysis and, when needed, glucose production from non-carbohydrate substrates.
3. The liver releases more glucose into the blood, opposing the fall.

Insulin and glucagon act in opposite directions but are not identical mirror images in every tissue: liver, muscle and adipose cells have different roles. Muscle glycogen supports that muscle rather than being the main source of blood glucose. This card covers hormonal negative feedback, not test strips or biosensor readouts.

A glucose test strip uses immobilised enzymes to convert glucose into a colour signal, while a blood-glucose biosensor converts an enzyme reaction into an electrical signal. The signal is interpreted as an estimate of glucose concentration within the method’s calibrated range.

Urine test-strip method:

1. Immerse the enzyme-containing pad in the urine sample for the specified short time.
2. If glucose is present, glucose oxidase produces hydrogen peroxide; peroxidase uses it in a second reaction that forms a coloured product.
3. Compare the pad colour with the supplied colour chart: darker colour corresponds to a higher glucose concentration in the chart range.
4. Treat the result as a urine-glucose indication, not a direct current blood-glucose reading.

Blood biosensor method:

1. A partially permeable membrane allows small molecules from the blood sample to reach immobilised glucose oxidase on the recognition layer.
2. Glucose oxidation produces hydrogen peroxide, whose electron transfer at an electrode creates a current.
3. Electron flow is related to glucose concentration; the processor converts the amplified signal into a digital reading.

Use the stated sample volume or immersion, timing and calibration/colour chart consistently; compare with appropriate controls or a known reference when the method provides them. Read only within the validated range and do not infer more precision than the colour scale or sensor supports.

Enzyme specificity makes the test selective for glucose. A urine strip indicates whether glucose was present in the urine and reflects earlier renal-threshold conditions; it does not show the current blood-glucose concentration. This card covers signal generation and reading, not insulin/glucagon feedback or a medical diagnosis.